🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to examine the toxicity profile, maximum tolera...
Status
Completed
Location
Multiple Locations
Start Date
2011-08
Trial ID
NCT02043756
Treatments Being Tested
This is a prospective, Bayesian adaptive, phase II clinical trial designed ...
Status
Recruiting
Location
Cancer Center of Guangzhou Medical University
Start Date
2025-06-24
Trial ID
NCT07070479
The primary objective of this study is to evaluate the efficacy of tisleliz...
Status
Terminated
Location
Beijing Cancer Hospital
Start Date
2020-12-14
Trial ID
NCT04486391
Treatments Being Tested
This is a single-arm, open-label clinical trial evaluating the safety and p...
Status
Recruiting
Location
Blood diseases hospital
Start Date
2026-05-08
Trial ID
NCT07490288
The goal of this clinical trial is to estimate the rate (probability) of co...
Status
Recruiting
Location
First Affiliated Hospital Of University of Science and Technology of China
Start Date
2024-01-01
Trial ID
NCT06221683
The purpose of this study is to evaluate the tolerability, safety, pharmaco...
Status
Unknown
Location
Multiple Locations
Start Date
2022-04
Trial ID
NCT05344742
Treatments Being Tested
A clinical study was conducted to evaluate the efficacy and safety of the R...
Status
Unknown
Location
The First Bethune Hospital of Jilin University
Start Date
2023-09-01
Trial ID
NCT05990985
to observe the dose-limiting toxicity (DLT) of liposomal mitoxantrone hydro...
Status
Recruiting
Location
The First Affiliated Hospital of Xiamen University
Start Date
2024-12-12
Trial ID
NCT06651866
Treatments Being Tested
This is a prospective, single arm, multicenter study to evaluate the safety...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-07-10
Trial ID
NCT06486337
Treatments Being Tested
This is a prospective, single arm, multicenter study to evaluate the safety...
Status
Unknown
Location
Tianjin Cancer Hospital
Start Date
2024-06-01
Trial ID
NCT06433362
Treatments Being Tested